Brain damage in preterm newborns and maternal medication: the ELGAN Study

Objective We sought to evaluate the association between maternal medication use during pregnancy and cerebral white matter damage and cerebral palsy (CP) among very preterm infants. Study Design This analysis of data from the Extremely Low Gestational Age Newborns (ELGAN) Study included 877 infants...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of obstetrics and gynecology 2012-09, Vol.207 (3), p.192.e1-192.e9
Hauptverfasser:	Tyler, Crystal P., PhD, Paneth, Nigel, MD, Allred, Elizabeth N., MS, Hirtz, Deborah, MD, Kuban, Karl, MD, McElrath, Thomas, MD, O'Shea, T. Michael, MD, Miller, Cindy, MD, Leviton, Alan, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Brain Injury, Chronic - chemically induced cerebral palsy Cerebral Palsy - chemically induced cerebral white matter damage Diseases of mother, fetus and pregnancy Female Gynecology. Andrology. Obstetrics Humans Infant, Newborn Infant, Premature Infant, Premature, Diseases - chemically induced Medical sciences Obstetrics and Gynecology Pregnancy Pregnancy Complications - drug therapy Pregnancy. Fetus. Placenta Prenatal Exposure Delayed Effects - chemically induced preterm Prospective Studies Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective We sought to evaluate the association between maternal medication use during pregnancy and cerebral white matter damage and cerebral palsy (CP) among very preterm infants. Study Design This analysis of data from the Extremely Low Gestational Age Newborns (ELGAN) Study included 877 infants born
ISSN:	0002-9378 1097-6868
DOI:	10.1016/j.ajog.2012.06.059